X-150470082-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_005491.5(MAMLD1):c.509C>T(p.Pro170Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000529 in 1,209,760 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005491.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAMLD1 | NM_005491.5 | c.509C>T | p.Pro170Leu | missense_variant | 4/8 | ENST00000370401.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAMLD1 | ENST00000370401.7 | c.509C>T | p.Pro170Leu | missense_variant | 4/8 | 5 | NM_005491.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 17AN: 111610Hom.: 0 Cov.: 23 AF XY: 0.000207 AC XY: 7AN XY: 33802
GnomAD3 exomes AF: 0.0000600 AC: 11AN: 183236Hom.: 0 AF XY: 0.0000443 AC XY: 3AN XY: 67728
GnomAD4 exome AF: 0.0000428 AC: 47AN: 1098094Hom.: 0 Cov.: 34 AF XY: 0.0000550 AC XY: 20AN XY: 363452
GnomAD4 genome AF: 0.000152 AC: 17AN: 111666Hom.: 0 Cov.: 23 AF XY: 0.000207 AC XY: 7AN XY: 33868
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.509C>T (p.P170L) alteration is located in exon 3 (coding exon 3) of the MAMLD1 gene. This alteration results from a C to T substitution at nucleotide position 509, causing the proline (P) at amino acid position 170 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 03, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at